Dutch biotech investor Forbion has raised two new funds to put into biotech companies, just 18 months after its last major ...

Novartis used one of its priority review vouchers (PRV) to speed the September approval of Kisqali in early breast cancer, ...

Eli Lilly plans to invest £279 million ($364 million) in the UK as part of a new government partnership in which the ...

Private equity firms TPG and Blackstone are working on a potential deal to buy Brent Saunders-led eye care company Bausch + ...

More than a year ago, Endpoints News made the decision that we needed a dedicated reporter covering the use of artificial ...

Novo Nordisk filed suit against another semaglutide compounder on Friday, bringing its total number of cases to 50. Both Novo ...

GSK announced another batch of positive data from its respiratory program with the investigational drug depemokimab, this ...

Novartis has terminated a mid-stage trial of an oral treatment candidate for idiopathic pulmonary fibrosis, the company ...

The full results from Pfizer’s pivotal study of its Duchenne muscular dystrophy gene therapy show patients saw no significant ...

The global cell and gene therapy (CGT) industry is poised for remarkable growth, driven by significant advances in life ...

Transgene’s therapeutic cancer vaccine candidate has failed a mid-stage test in certain HPV-driven cancers, sending its ...

Novo Holdings is set to buy one less facility from Catalent as the manufacturer has sold a facility in New Jersey to a ...